OrbusNeich Medical Group Holdings Limited provides earnings guidance for the six months ended June 30, 2023. The Group is expected to record (i) an increase in profit for the period attributable to owners of the Company by over 200% as compared with that for the six months ended June 30, 2022 and (ii) an increase in adjusted profit for the period (non-HKFRS measure Note) by over 100% as compared with that for the Previous Period. The increase in profit for the period attributable to owners of the Company is mainly attributable to the following factors: (i) increase in gross profit arising from the increase in sales of the Group's balloons; (ii) increase in interest income from bank deposits; and (iii) listing expenses did not recur for the Current Period as the listing of the Company was completed in 2022.
OrbusNeich Medical Group Holdings Limited
Equities
6929
KYG6773B1005
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 HKD | 0.00% | +9.73% | -36.03% |
Mar. 07 | OrbusNeich Medical Group’s Profit Up 144% in 2023 | MT |
Mar. 07 | OrbusNeich Medical Group Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 28 June 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.03% | 478M | |
+8.29% | 124B | |
-5.61% | 11.17B | |
+4.83% | 9.17B | |
+39.60% | 5.59B | |
-22.04% | 4.71B | |
+8.39% | 3.44B | |
-6.28% | 2.88B | |
-10.23% | 2.11B | |
-5.99% | 2.09B |
- Stock Market
- Equities
- 6929 Stock
- News OrbusNeich Medical Group Holdings Limited
- OrbusNeich Medical Group Holdings Limited Provides Earnings Guidance for the Six Months Ended June 30, 2023